Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-16

FDA Approved: DEPO-SUBQ PROVERA — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved a supplemental application for Depo-SubQ Provera, an injectable contraceptive containing medroxyprogesterone acetate, submitted by Pharmacia & …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE)

Snippet

SUPPL AP for DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE)